Bajaj Healthcare Limited (BAJAJHCARE) - Total Liabilities

Latest as of September 2025: Rs3.52 Billion INR ≈ $38.12 Million USD

Based on the latest financial reports, Bajaj Healthcare Limited (BAJAJHCARE) has total liabilities worth Rs3.52 Billion INR (≈ $38.12 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Bajaj Healthcare Limited to assess how effectively this company generates cash.

Bajaj Healthcare Limited - Total Liabilities Trend (2011–2025)

This chart illustrates how Bajaj Healthcare Limited's total liabilities have evolved over time, based on quarterly financial data. Check Bajaj Healthcare Limited liquidity resilience to evaluate the company's liquid asset resilience ratio.

Bajaj Healthcare Limited Competitors by Total Liabilities

The table below lists competitors of Bajaj Healthcare Limited ranked by their total liabilities.

Company Country Total Liabilities
Siam Pan Group PCL
BK:SPG
Thailand ฿457.05 Million
Bcl Industries Limited
NSE:BCLIND
India Rs7.94 Billion
Gandhi Special Tubes Limited
NSE:GANDHITUBE
India Rs248.47 Million
Action SA
WAR:ACT
Poland zł314.76 Million
Axcen Photonics
TWO:6530
Taiwan NT$64.67 Million
DreamCIS Inc
KQ:223250
Korea ₩60.03 Billion
Cti Logistics Ltd
AU:CLX
Australia AU$184.48 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Bajaj Healthcare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BAJAJHCARE stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.75 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.72 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.42 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bajaj Healthcare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bajaj Healthcare Limited (2011–2025)

The table below shows the annual total liabilities of Bajaj Healthcare Limited from 2011 to 2025.

Year Total Liabilities Change
2025-03-31 Rs3.67 Billion
≈ $39.68 Million
-24.63%
2024-03-31 Rs4.87 Billion
≈ $52.64 Million
-8.81%
2023-03-31 Rs5.34 Billion
≈ $57.73 Million
+35.95%
2022-03-31 Rs3.93 Billion
≈ $42.46 Million
+46.93%
2021-03-31 Rs2.67 Billion
≈ $28.90 Million
+53.45%
2020-03-31 Rs1.74 Billion
≈ $18.83 Million
+26.42%
2019-03-31 Rs1.38 Billion
≈ $14.90 Million
-10.86%
2018-03-31 Rs1.55 Billion
≈ $16.71 Million
+28.51%
2017-03-31 Rs1.20 Billion
≈ $13.00 Million
-0.12%
2016-03-31 Rs1.20 Billion
≈ $13.02 Million
+12.75%
2015-03-31 Rs1.07 Billion
≈ $11.55 Million
-6.22%
2014-03-31 Rs1.14 Billion
≈ $12.31 Million
+12.27%
2013-03-31 Rs1.01 Billion
≈ $10.97 Million
+11.64%
2012-03-31 Rs908.41 Million
≈ $9.82 Million
+23.55%
2011-03-31 Rs735.24 Million
≈ $7.95 Million
--

About Bajaj Healthcare Limited

NSE:BAJAJHCARE India Drug Manufacturers - Specialty & Generic
Market Cap
$114.95 Million
Rs10.63 Billion INR
Market Cap Rank
#18680 Global
#995 in India
Share Price
Rs336.55
Change (1 day)
-0.93%
52-Week Range
Rs278.20 - Rs602.80
All Time High
Rs712.20
About

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, … Read more